And deactivation of EGFR, AKT or GSK3β with its corresponding inhibitor could block shATF3 induced β−catenin expression, cell proliferation and cell invasion in ccRCC cells, suggesting they formed as one central signaling axis to promote ccRCC development. Here, AKT1 is linked to nonpapillary renal cell carcinoma.